Metan Pharmaceuticals Private Limited
About Metan Pharmaceuticals Private Limited
Data last updated:
Metan Pharmaceuticals Private Limited is a private limited company based in Guntur, Andhra Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 01 June 2022.
The company is registered with the Registrar of Companies (ROC), Vijayawada, under CIN U24290AP2022PTC121870.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Viswanath Mallela and Rama Krishna Mamidi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H.No.6 – 30 – 123/9 Ward No – 9 Arundelpet, Guntur, Andhra Pradesh, India – 522002.
As per the financials filed for FY 2025, the company reported a revenue of ₹31.3 Lakh, a growth of 49% compared to the previous year. For the same year it recorded a net loss of ₹7.35 Lakh (net margin -23.5%) and EBITDA of -₹6.84 Lakh (EBITDA margin -21.9%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Metan Pharmaceuticals Private Limited's registered office is in Guntur, Andhra Pradesh.
- Registered AddressH.No.6 – 30 – 123/9 Ward No – 9 Arundelpet, Guntur, Andhra Pradesh, India – 522002
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Metan Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Metan Pharmaceuticals Private Limited, buy the company report.
Financials of Metan Pharmaceuticals Private Limited
FY 2025 filings availableMetan Pharmaceuticals Private Limited reported revenue of ₹31.3 Lakh (up 49% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 49% in the latest year. EBITDA rose 16% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹6.84 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹7.35 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -21.9% | ||
| Net Profit Margin | -23.5% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Metan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Metan Pharmaceuticals Private Limited
Metan Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Viswanath Mallela Also directs: Docheal Pharma Private Limited | Director | 01 Jun 2022 | 4 Years 4 Months | Current |
| Rama Krishna Mamidi | Director | 01 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Metan Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Frederick Abett Pharmaceuticals Private Limited | ₹31.44 Lakh (FY 2024) | -15.0% | Agra, Uttar Pradesh, India | |||
| Metan Pharmaceuticals Private Limitedthis company | ₹31.3 Lakh (FY 2025) | -₹7.35 Lakh | -23.5% | 49.0% | Guntur, Andhra Pradesh, India | |
| Exide Healthcare Pharmaceuticals Private Limited | ₹31.26 Lakh (FY 2025) | -25.0% | New Delhi, Delhi, India | |||
| Aspriant Pharmaceuticals Private Limited | ₹31.19 Lakh (FY 2024) | 100.0% | Washim, Maharashtra, India |
To see the full peer comparison of Metan Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Metan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Metan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Metan Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Metan Pharmaceuticals Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Rama Krishna Mamidi was appointed as Director on 01 Jun 2022.
Frequently asked questions
Metan Pharmaceuticals is an active private limited company based in Guntur, Andhra Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 01 June 2022 (4+ years old) and is registered under CIN U24290AP2022PTC121870.
Metan Pharmaceuticals has 2 current directors:
- Viswanath Mallela - Director
- Rama Krishna Mamidi - Director
The latest financial statements of Metan Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Metan Pharmaceuticals is U24290AP2022PTC121870. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Metan Pharmaceuticals was incorporated on 01 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Vijayawada.
The peers of Metan Pharmaceuticals by revenue are Frederick Abett Pharmaceuticals Private Limited, Exide Healthcare Pharmaceuticals Private Limited, Aspriant Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Rama Krishna Mamidi was appointed as Director on 01 Jun 2022. Viswanath Mallela was appointed as Director on 01 Jun 2022.
The registered office of Metan Pharmaceuticals is at H.No.6 – 30 – 1239 Ward No – 9 Arundelpet, Guntur, Andhra Pradesh, India – 522002.
Metan Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
The compliance status of Metan Pharmaceuticals is compliant as of 21 September 2026. The company is actively filing with the Registrar of Companies.
Metan Pharmaceuticals can be reached at its registered office: H.No.6 – 30 – 1239 Ward No – 9 Arundelpet, Guntur, Andhra Pradesh, India – 522002.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
